Initial and updated recommendations
| Recommendation . | Population . | Anticoagulation intensities being compared . | First version∗ . | Update∗ . | Update for executive summary∗ . |
|---|---|---|---|---|---|
| 1a | Patients with COVID-19 who are critically ill | Prophylactic vs intermediate | October 2020 | June 2021 | April 2024 |
| 1b | Patients with COVID-19 who are critically ill | Prophylactic vs therapeutic | October 2020 | April 2022 | April 2024 |
| 2a | Patients with COVID-19 who are acutely ill | Prophylactic vs intermediate | October 2020 | July 2022† | April 2024 |
| 2b | Patients with COVID-19 who are acutely ill | Prophylactic vs therapeutic | October 2020 | March 2022 | April 2024 |
| 3 | Patients with COVID-19 being discharged | Prophylactic vs none | August 2021 | August 2022 | April 2024 |
| Recommendation . | Population . | Anticoagulation intensities being compared . | First version∗ . | Update∗ . | Update for executive summary∗ . |
|---|---|---|---|---|---|
| 1a | Patients with COVID-19 who are critically ill | Prophylactic vs intermediate | October 2020 | June 2021 | April 2024 |
| 1b | Patients with COVID-19 who are critically ill | Prophylactic vs therapeutic | October 2020 | April 2022 | April 2024 |
| 2a | Patients with COVID-19 who are acutely ill | Prophylactic vs intermediate | October 2020 | July 2022† | April 2024 |
| 2b | Patients with COVID-19 who are acutely ill | Prophylactic vs therapeutic | October 2020 | March 2022 | April 2024 |
| 3 | Patients with COVID-19 being discharged | Prophylactic vs none | August 2021 | August 2022 | April 2024 |